메뉴 건너뛰기




Volumn 108, Issue 2, 2012, Pages 285-290

The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors

Author keywords

Chemo brain; Chemotherapy; Cognition; Glioblastoma; Oligodendroglioma; Primary brain tumor; Primary CNS lymphoma

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; BEVACIZUMAB; CORTICOSTEROID; METHOTREXATE; TEMOZOLOMIDE;

EID: 84864056178     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0807-6     Document Type: Review
Times cited : (27)

References (51)
  • 1
    • 79956216585 scopus 로고    scopus 로고
    • An update on cancer- and chemotherapy-related cognitive dysfunction: Current status
    • Janelsins MC, Kohli S, Mohile SG et al (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38:431-438
    • (2011) Semin Oncol , vol.38 , pp. 431-438
    • Janelsins, M.C.1    Kohli, S.2    Mohile, S.G.3
  • 2
    • 79959558529 scopus 로고    scopus 로고
    • International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer
    • Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703-708
    • (2011) Lancet Oncol , vol.12 , pp. 703-708
    • Wefel, J.S.1    Vardy, J.2    Ahles, T.3    Schagen, S.B.4
  • 3
    • 77952217466 scopus 로고    scopus 로고
    • Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy- induced 'chemo-fog'
    • Raffa RB, Tallarida RJ (2010) Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy- induced 'chemo-fog'. J Clin Pharm Ther 35:249-255
    • (2010) J Clin Pharm Ther , vol.35 , pp. 249-255
    • Raffa, R.B.1    Tallarida, R.J.2
  • 4
    • 33846991965 scopus 로고    scopus 로고
    • CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and vivo
    • Dietrich J, Han R, Yang Y et al (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and vivo. J Biol 5:1-23
    • (2006) J Biol , vol.5 , pp. 1-23
    • Dietrich, J.1    Han, R.2    Yang, Y.3
  • 5
    • 58749089099 scopus 로고    scopus 로고
    • Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy
    • Dietrich J, Monje M, Wefel J et al (2008) Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 13:1285-1295
    • (2008) Oncologist , vol.13 , pp. 1285-1295
    • Dietrich, J.1    Monje, M.2    Wefel, J.3
  • 6
    • 0345107251 scopus 로고    scopus 로고
    • Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging perspectives
    • Saykin AJ, Ahles TA, McDonald BC (2003) Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 8:201-216 (Pubitemid 37474731)
    • (2003) Seminars in Clinical Neuropsychiatry , vol.8 , Issue.4 , pp. 201-216
    • Saykin, A.J.1    Ahles, T.A.2    McDonald, B.C.3
  • 7
    • 78650923263 scopus 로고    scopus 로고
    • Evidence for acute neurotoxicity after chemotherapy
    • Petzold A, Mondria T, Kuhle J et al (2010) Evidence for acute neurotoxicity after chemotherapy. Ann Neurol 68:806-815
    • (2010) Ann Neurol , vol.68 , pp. 806-815
    • Petzold, A.1    Mondria, T.2    Kuhle, J.3
  • 8
    • 77956646449 scopus 로고    scopus 로고
    • The impact of chemo brain on the patient with a high-grade glioma
    • Lucas MR (2010) The impact of chemo brain on the patient with a high-grade glioma. Adv Exp Med Biol 678:21-25
    • (2010) Adv Exp Med Biol , vol.678 , pp. 21-25
    • Lucas, M.R.1
  • 10
    • 77954947310 scopus 로고    scopus 로고
    • Neurocognitive function in brain tumors
    • Correa DD (2010) Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 10:232-239
    • (2010) Curr Neurol Neurosci Rep , vol.10 , pp. 232-239
    • Correa, D.D.1
  • 11
    • 70349319721 scopus 로고    scopus 로고
    • Central nervous system effects of natural and synthetic glucocorticoids
    • Fietta P, Fietta P, Delsante G (2009) Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci 63(5):613-622
    • (2009) Psychiatry Clin Neurosci , vol.63 , Issue.5 , pp. 613-622
    • Fietta, P.1    Fietta, P.2    Delsante, G.3
  • 12
    • 0030001481 scopus 로고    scopus 로고
    • Neuropsychiatric disorders in cancer patients
    • Baile WF (1996) Neuropsychiatric disorders in cancer patients. Curr Opin Oncol 8(3):182-187 (Pubitemid 26200845)
    • (1996) Current Opinion in Oncology , vol.8 , Issue.3 , pp. 182-187
    • Baile, W.F.1
  • 13
    • 11344272898 scopus 로고    scopus 로고
    • Complications of radiation therapy on the brain and spinal cord
    • DOI 10.1055/s-2004-861535
    • Béhin A, Delattre JY (2004) Complications of radiation therapy on the brain and spinal cord. Semin Neurol 24(4):405-417 (Pubitemid 40076117)
    • (2004) Seminars in Neurology , vol.24 , Issue.4 , pp. 405-417
    • Behin, A.1    Delattre, J.-Y.2
  • 16
    • 33644497225 scopus 로고    scopus 로고
    • Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: Preliminary findings
    • Correa DD, Anderson ND, Glass A et al (2003) Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings. Clin Adv Hematol Oncol 1:490
    • (2003) Clin Adv Hematol Oncol , vol.1 , pp. 490
    • Correa, D.D.1    Anderson, N.D.2    Glass, A.3
  • 18
    • 20144387340 scopus 로고    scopus 로고
    • Neuropsychological outcome after chemotherapy for primary CNS lymphoma: A prospective study
    • Fliessbach K, Helmstaedter C, Urbach H et al (2005) Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 64:1184-1188
    • (2005) Neurology , vol.64 , pp. 1184-1188
    • Fliessbach, K.1    Helmstaedter, C.2    Urbach, H.3
  • 20
    • 0034962791 scopus 로고    scopus 로고
    • Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: A pilot study
    • Schlegel U, Pels H, Glasmacher A et al (2001) Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatr 71:118-122
    • (2001) J Neurol Neurosurg Psychiatr , vol.71 , pp. 118-122
    • Schlegel, U.1    Pels, H.2    Glasmacher, A.3
  • 22
    • 0033986092 scopus 로고    scopus 로고
    • Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma
    • McAllister LD, Doolittle ND, Guastadisegni PE et al (2000) Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46:51-60
    • (2000) Neurosurgery , vol.46 , pp. 51-60
    • McAllister, L.D.1    Doolittle, N.D.2    Guastadisegni, P.E.3
  • 23
    • 1342309530 scopus 로고    scopus 로고
    • Cognitive functions in survivors of primary central nervous system lymphoma
    • Correa DD, DeAngelis LM, Shi W et al (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62:548-555 (Pubitemid 38252794)
    • (2004) Neurology , vol.62 , Issue.4 , pp. 548-555
    • Correa, D.D.1    DeAngelis, L.M.2    Shi, W.3    Thaler, H.4    Glass, A.5    Abrey, L.E.6
  • 24
    • 73349134695 scopus 로고    scopus 로고
    • NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
    • Wick W, Hartmann C, Engel C et al (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874-5880
    • (2009) J Clin Oncol , vol.27 , pp. 5874-5880
    • Wick, W.1    Hartmann, C.2    Engel, C.3
  • 25
    • 79959978296 scopus 로고    scopus 로고
    • International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
    • Lassman AB, Iwamoto FM, Cloughesy TF et al (2011) International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol 13:649-659
    • (2011) Neuro Oncol , vol.13 , pp. 649-659
    • Lassman, A.B.1    Iwamoto, F.M.2    Cloughesy, T.F.3
  • 27
    • 84864027175 scopus 로고    scopus 로고
    • A phase III intergroup study of radiotherapy versus temozolomide alone versus radiotherapy with concomitant and adjuvant temozolomide for patients with 1p/19q codeleted anaplastic glioma
    • A phase III intergroup study of radiotherapy versus temozolomide alone versus radiotherapy with concomitant and adjuvant temozolomide for patients with 1p/19q codeleted anaplastic glioma. ClinicalTrials.gov identifier: NCT00887146
    • Clinical Trials. Gov Identifier
  • 28
    • 77955817286 scopus 로고    scopus 로고
    • European federation of neurological societies. Guidelines on management of low-grade gliomas: Report of an EFNS-EANO task force
    • Soffietti R, Baumert BG, Bello L (2010) European federation of neurological societies. Guidelines on management of low-grade gliomas: report of an EFNS-EANO task force. Eur J Neurol 17(9):1124-1133
    • (2010) Eur J Neurol , vol.17 , Issue.9 , pp. 1124-1133
    • Soffietti, R.1    Baumert, B.G.2    Bello, L.3
  • 29
    • 0029888804 scopus 로고    scopus 로고
    • Low-grade oligodendroglioma responds to chemotherapy
    • Mason WP, Krol GS, DeAngelis LM (1996) Low-grade oligodendroglioma responds to chemotherapy. Neurology 46(1):203- 207 (Pubitemid 26156130)
    • (1996) Neurology , vol.46 , Issue.1 , pp. 203-207
    • Mason, W.P.1    Krol, G.S.2    DeAngelis, L.M.3
  • 31
    • 58949090060 scopus 로고    scopus 로고
    • Phase II study of protracted daily temozolomide for low-grade gliomas in adults
    • Kesari S, Schiff D, Drappatz J et al (2009) Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res 15(1):330-337
    • (2009) Clin Cancer Res , vol.15 , Issue.1 , pp. 330-337
    • Kesari, S.1    Schiff, D.2    Drappatz, J.3
  • 32
    • 38049095060 scopus 로고    scopus 로고
    • Longitudinal cognitive follow-up in low grade gliomas
    • Correa DD, Shi W, Thaler HT et al (2008) Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol 86(3):321-327
    • (2008) J Neurooncol , vol.86 , Issue.3 , pp. 321-327
    • Correa, D.D.1    Shi, W.2    Thaler, H.T.3
  • 33
    • 79957516708 scopus 로고    scopus 로고
    • Response assessment in neuro-oncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas
    • van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12(6):583-593
    • (2011) Lancet Oncol , vol.12 , Issue.6 , pp. 583-593
    • Van Den Bent, M.J.1    Wefel, J.S.2    Schiff, D.3
  • 34
    • 84864057986 scopus 로고    scopus 로고
    • A phase III randomized study of radiotherapy versus temozolomide in patients with low-grade gliomas
    • A phase III randomized study of radiotherapy versus temozolomide in patients with low-grade gliomas. ClinicalTrials.gov identifier: NCT00182819
    • ClinicalTrials.gov Identifier
  • 35
    • 84864057987 scopus 로고    scopus 로고
    • A phase III study of radiation therapy with or without temozolomide for symptomatic or progressive low-grade gliomas
    • A phase III study of radiation therapy with or without temozolomide for symptomatic or progressive low-grade gliomas. ClinicalTrials. gov identifier: NCT00978458
    • ClinicalTrials. Gov Identifier
  • 38
    • 77952557556 scopus 로고    scopus 로고
    • Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation therapy oncology group trial 9402
    • Wang M, Cairncross G, Shaw E et al (2010) Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Int J Radiat Oncol Biol Phys 77:662-669
    • (2010) Int J Radiat Oncol Biol Phys , vol.77 , pp. 662-669
    • Wang, M.1    Cairncross, G.2    Shaw, E.3
  • 39
    • 37649008911 scopus 로고    scopus 로고
    • Healthrelated quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: Results of a European Organisation for research and treatment of cancer randomized clinical trial
    • Taphoorn MJ, van den Bent MJ, Mauer ME et al (2007) Healthrelated quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for research and treatment of cancer randomized clinical trial. J Clin Oncol 25:5723-5730
    • (2007) J Clin Oncol , vol.25 , pp. 5723-5730
    • Taphoorn, M.J.1    Van Den Bent, M.J.2    Mauer, M.E.3
  • 43
    • 65349121788 scopus 로고    scopus 로고
    • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    • Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
    • (2009) Lancet Oncol , vol.10 , pp. 459-466
    • Stupp, R.1    Hegi, M.E.2    Mason, W.P.3
  • 44
    • 77949264925 scopus 로고    scopus 로고
    • Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: Initial findings
    • Hilverda K, Bosma I, Heimans JJ et al (2010) Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings. J Neurooncol 97:89-94
    • (2010) J Neurooncol , vol.97 , pp. 89-94
    • Hilverda, K.1    Bosma, I.2    Heimans, J.J.3
  • 45
    • 79955748407 scopus 로고    scopus 로고
    • Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: A retrospective review of 206 cases
    • Scott JG, Suh JH, Elson P et al (2011) Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol 13:428-436
    • (2011) Neuro Oncol , vol.13 , pp. 428-436
    • Scott, J.G.1    Suh, J.H.2    Elson, P.3
  • 46
    • 68149182696 scopus 로고    scopus 로고
    • Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: Correlation with MGMT promoter methylation status
    • Brandes AA, Franceschi E, Tosoni A et al (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115:3512-3518
    • (2009) Cancer , vol.115 , pp. 3512-3518
    • Brandes, A.A.1    Franceschi, E.2    Tosoni, A.3
  • 47
    • 42349090207 scopus 로고    scopus 로고
    • Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
    • Minniti G, De Sanctis V, Muni R et al (2008) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88:97-103
    • (2008) J Neurooncol , vol.88 , pp. 97-103
    • Minniti, G.1    De Sanctis, V.2    Muni, R.3
  • 48
    • 46949100273 scopus 로고    scopus 로고
    • Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
    • Sijben AE, McIntyre JB, Roldán GB et al (2008) Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol 89:97-103
    • (2008) J Neurooncol , vol.89 , pp. 97-103
    • Sijben, A.E.1    McIntyre, J.B.2    Roldán, G.B.3
  • 49
    • 84864047031 scopus 로고    scopus 로고
    • A randomized phase III study of temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients
    • A randomized phase III study of temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients. Clinicaltrials.gov identifier: NCT00482677
    • Clinicaltrials.gov Identifier
  • 50
    • 80051659072 scopus 로고    scopus 로고
    • Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: An ANOCEF phase II trial
    • Gállego Pérez-Larraya J, Ducray F, Chinot O et al (2011) Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol 29(22):3050-3055
    • (2011) J Clin Oncol , vol.29 , Issue.22 , pp. 3050-3055
    • Gállego Pérez-Larraya, J.1    Ducray, F.2    Chinot, O.3
  • 51
    • 79959947030 scopus 로고    scopus 로고
    • Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
    • Wefel JS, Cloughesy T, Zazzali JL et al (2011) Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13:660-668
    • (2011) Neuro Oncol , vol.13 , pp. 660-668
    • Wefel, J.S.1    Cloughesy, T.2    Zazzali, J.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.